These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17304047)

  • 1. Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis.
    Taioli E; Benhamou S; Bouchardy C; Cascorbi I; Cajas-Salazar N; Dally H; Fong KM; Larsen JE; Le Marchand L; London SJ; Risch A; Spitz MR; Stucker I; Weinshenker B; Wu X; Yang P
    Genet Med; 2007 Feb; 9(2):67-73. PubMed ID: 17304047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
    Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
    Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
    Arslan S; Pinarbasi H; Silig Y
    Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene.
    Cascorbi I; Henning S; Brockmöller J; Gephart J; Meisel C; Müller JM; Loddenkemper R; Roots I
    Cancer Res; 2000 Feb; 60(3):644-9. PubMed ID: 10676648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.
    Xu LL; Liu G; Miller DP; Zhou W; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1555-9. PubMed ID: 12496043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A myeloperoxidase polymorphism associated with reduced risk of lung cancer.
    Schabath MB; Spitz MR; Hong WK; Delclos GL; Reynolds WF; Gunn GB; Whitehead LW; Wu X
    Lung Cancer; 2002 Jul; 37(1):35-40. PubMed ID: 12057865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
    Feyler A; Voho A; Bouchardy C; Kuokkanen K; Dayer P; Hirvonen A; Benhamou S
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1550-4. PubMed ID: 12496042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.
    Zhou C; Luo Q; Qing Y; Lin X; Zhan Y; Ouyang M
    Tumour Biol; 2013 Dec; 34(6):3449-55. PubMed ID: 23943394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between myeloperoxidase G-463A polymorphism and lung cancer risk.
    Huang C; Ma L; Li D
    Tumour Biol; 2014 Jan; 35(1):475-81. PubMed ID: 23943392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population.
    Lu W; Xing D; Qi J; Tan W; Miao X; Lin D
    Int J Cancer; 2002 Nov; 102(3):275-9. PubMed ID: 12397651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori seropositivity and the myeloperoxidase G-463A polymorphism in combination with interleukin-1B C-31T in Japanese health checkup examinees.
    Katsuda N; Hamajima N; Tamakoshi A; Wakai K; Matsuo K; Saito T; Tajima K; Tominaga S
    Jpn J Clin Oncol; 2003 Apr; 33(4):192-7. PubMed ID: 12810834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis.
    Tang N; Wang Y; Mei Q
    Gene; 2013 Jul; 523(2):152-7. PubMed ID: 23583798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A meta analysis on the relationship between myeloperoxidase G-463A genetic polymorphisms and lung cancer susceptibility].
    Hua F; Wang J; Gu J; Li S; Liu H; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):122-7. PubMed ID: 20673504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between myeloperoxidase 463G>A polymorphisms and risk of lung cancer in East-Asia population.
    Hou X; Gao Y; Duan Y; Wang Z; Shi L; Ma J; Xie X
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C97-100. PubMed ID: 26323935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase G463A polymorphism and risk of lung cancer.
    Li J; Fu Y; Zhao B; Xiao Y; Chen R
    Tumour Biol; 2014 Jan; 35(1):821-9. PubMed ID: 23979979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
    Yang WJ; Wang MY; Pan FZ; Shi C; Cen H
    World J Surg Oncol; 2017 Aug; 15(1):144. PubMed ID: 28764808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung cancer risk associated with genetic polymorphism in myeloperoxidase (-463 G/A) in a Chinese population].
    Lu W; Qi J; Xing D; Tan W; Miao X; Su W; Wu M; Lin D
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):250-3. PubMed ID: 12515618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study.
    Zhu H; Yang L; Zhou B; Yu R; Tang N; Wang B
    Carcinogenesis; 2006 Dec; 27(12):2491-6. PubMed ID: 16829688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.